ATLAS / Macro Radar / Reporting / JANX

Janux Therapeutics, Inc. (JANX) reporting calendar

Janux Therapeutics, Inc. files periodic reports with the SEC as JANX on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
28 Jul 2026 – 17 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open JANX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-212146
10-K31 Dec 202526 Feb 202657 days0001193125-26-076918
10-Q30 Sep 20256 Nov 202537 days0001193125-25-269799
10-Q30 Jun 20257 Aug 202538 days0000950170-25-105069
10-Q31 Mar 20258 May 202538 days0000950170-25-067083
10-K31 Dec 202427 Feb 202558 days0000950170-25-029177
10-Q30 Sep 20246 Nov 202437 days0000950170-24-122370
10-Q30 Jun 20247 Aug 202438 days0000950170-24-092857
10-Q31 Mar 20248 May 202438 days0000950170-24-054966
10-K31 Dec 20238 Mar 202468 days0000950170-24-028659
10-Q30 Sep 20237 Nov 202338 days0000950170-23-060288
10-Q30 Jun 20238 Aug 202339 days0000950170-23-039898
10-Q31 Mar 20239 May 202339 days0000950170-23-019689
10-K31 Dec 202210 Mar 202369 days0000950170-23-007311
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024511
10-Q30 Jun 20229 Aug 202240 days0000950170-22-016082
10-Q31 Mar 202210 May 202240 days0000950170-22-008984
10-K31 Dec 202118 Mar 202277 days0000950170-22-004171
10-Q30 Sep 20219 Nov 202140 days0000950170-21-003738
10-Q30 Jun 202110 Aug 202141 days0000950170-21-001188

Source: SEC EDGAR company submissions for CIK 0001817713. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.